Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task

被引：4
|
作者：
Ariëns, RAS [1 ]
机构：
[1] Univ Leeds, LIGHT, Acad Mol Vasc Med, Leeds LS2 9JT, W Yorkshire, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2005.01263.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [11] Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage
    Brady, Kenneth M.
    Easley, R. Blaine
    Tobias, Joseph D.
    PEDIATRIC ANESTHESIA, 2006, 16 (10) : 1042 - 1046
  • [12] Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)
    S. Segal
    I. Y. Shemesh
    R. Blumenthal
    B. Yoffe
    N. Laufer
    Y. Ezra
    I. Levy
    M. Mazor
    U. Martinowitz
    Archives of Gynecology and Obstetrics, 2003, 268 (4) : 266 - 267
  • [13] Using recombinant activated factor VII (rFVIIa) in refractory bleeding: A community hospital experience.
    Muslimani, Alaa
    Daw, Hamed
    BLOOD, 2006, 108 (11) : 90B - 91B
  • [14] Benefits and risks of recombinant activated factor VII (rFVIIa) in massive bleeding: a single centre study
    Panizo, E.
    Lecumberri, R.
    Rodriguez-Otero, P.
    Hernandez, M.
    Pegenaute, C.
    Paramo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1160 - 1160
  • [15] Use of recombinant activated factor VII (rFVIIa) for acute reversal of warfarin in a child.
    Wu, JK
    Riding, RH
    George, SG
    BLOOD, 2002, 100 (11) : 120B - 121B
  • [16] UNCONTROLLED MASSIVE BLEEDING - COAGULOPATHY AND THE USE OF RFVIIA
    Hareuveni, M.
    Rozovski, U.
    Svorai-Litvak, S.
    Ben-Tal, O.
    VOX SANGUINIS, 2010, 99 : 435 - 435
  • [17] Off-label use of recombinant activated factor VII (rFVIIa) in children.
    Punzalan, RC
    Ghanayem, NS
    Gill, JC
    Jaquiss, RDB
    Montgomery, RR
    Gottschall, JL
    BLOOD, 2003, 102 (11) : 137B - 137B
  • [18] Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
    Tiede, A.
    Friedrich, U.
    Stenmo, C.
    Allen, G.
    Giangrande, P.
    Goudemand, J.
    Hay, C.
    Holmstrom, M.
    Klamroth, R.
    Lethagen, S.
    McKenzie, S.
    Miesbach, W.
    Negrier, C.
    Yuste, V. J.
    Berntorp, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (06) : 1191 - 1199
  • [19] Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
    Nicosia, Dario
    Federico, Antonin
    Vigna, Ivan
    Iozzo, Pasquale
    Misseri, Giovanni
    Cortegiani, Andrea
    CLINICAL CASE REPORTS, 2019, 7 (04): : 665 - 667
  • [20] Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
    Brackmann, HH
    Effenberger, W
    Hess, L
    Schwaab, R
    Oldenburg, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 : 18 - 23
12345